The price of Alphatec Holdings Inc. (NASDAQ:ATEC) shares last traded on Wall Street rose 1.52% to $12.01.
As we calculate the median target price by taking the range between a high of $22.50 and a low of $12.00, we find $15.75. Given the previous closing price of $11.83, this indicates a potential upside of 33.14 percent. ATEC stock price is now 17.06% away from the 50-day moving average and 31.00% away from the 200-day moving average. The market capitalization of the company currently stands at $1.23B.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
Brokers who have rated the stock have averaged $16.90 as their price target over the next twelve months.
With the price target of $12, Jefferies recently initiated with Buy rating for Alphatec Holdings Inc. (NASDAQ: ATEC). On September 12, 2022, Morgan Stanley recently initiated its ‘Overweight’ rating on the stock quoting a target price of $13, while ‘Goldman’ rates the stock as ‘Neutral’.
In other news, TULLIS JAMES L L, Director sold 50,000 shares of the company’s stock on Dec 16. The stock was sold for $529,500 at an average price of $10.59. Upon completion of the transaction, the Director now directly owns 497,974 shares in the company, valued at $5.98 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 05, EVP, SALES Sponsel David sold 10,000 shares of the business’s stock. A total of $98,800 was realized by selling the stock at an average price of $9.88. This leaves the insider owning 556,983 shares of the company worth $6.69 million. Insiders disposed of 2,856,657 shares of company stock worth roughly $34.31 million over the past 1 year. A total of 8.40% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in ATEC stock. A new stake in Alphatec Holdings Inc. shares was purchased by ALTIUM CAPITAL MANAGEMENT LP during the first quarter worth $4,107,000. FORMULA GROWTH LTD invested $2,702,000 in shares of ATEC during the first quarter. In the first quarter, EXODUSPOINT CAPITAL MANAGEMENT, LP acquired a new stake in Alphatec Holdings Inc. valued at approximately $1,095,000. JANE STREET GROUP, LLC acquired a new stake in ATEC for approximately $848,000. OCCUDO QUANTITATIVE STRATEGIES LP purchased a new stake in ATEC valued at around $460,000 in the second quarter. In total, there are 218 active investors with 51.00% ownership of the company’s stock.
A candlestick chart of Alphatec Holdings Inc. (NASDAQ: ATEC) showed a price of $11.96 on Wednesday morning. During the past 12 months, Alphatec Holdings Inc. has had a low of $5.73 and a high of $13.65. The fifty day moving average price for ATEC is $10.26 and a two-hundred day moving average price translates $9.17 for the stock.
The latest earnings results from Alphatec Holdings Inc. (NASDAQ: ATEC) was released for Jun, 2022. According to the Medical Devices Company, earnings per share came in at -$0.36, missing analysts’ expectations of -$0.29 by -0.07. This compares to -$0.43 EPS in the same period last year. The net profit margin was -49.30% and return on equity was -575.40% for ATEC. The company reported revenue of $89.84 million for the quarter, compared to $62.88 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 42.87 percent. For the current quarter, analysts expect ATEC to generate $82.18M in revenue.
Alphatec Holdings Inc.(ATEC) Company Profile
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
